home / stock / agtc / agtc news


AGTC News and Press, Applied Genetic Technologies Corporation From 12/03/19

Stock Information

Company Name: Applied Genetic Technologies Corporation
Stock Symbol: AGTC
Market: NASDAQ
Website: agtc.com

Menu

AGTC AGTC Quote AGTC Short AGTC News AGTC Articles AGTC Message Board
Get AGTC Alerts

News, Short Squeeze, Breakout and More Instantly...

AGTC - Applied Genetics Technology Corporation: Strong Science And Clinical Efficacy

Have you seen the explosion in biotech stocks of late? There may be another in the works. Applied Genetics Technology Corporation ( AGTC ) is an ocular gene therapy company that is markedly undervalued given the strength of its lead program and the breadth of its pipeline. The company's scie...

AGTC - AGTC Announces Departure of Chief Medical Officer, Company on Track to Announce XLRP and ACHM Data in January 2020

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 02, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announce...

AGTC - Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q1 2020 Results - Earnings Call Transcript

Applied Genetic Technologies Corporation (AGTC) Q1 2020 Results Earnings Conference Call November 12, 2019, 4:30 pm ET Company Participants Sue Washer - President, Chief Executive Officer Theresa Heah - Chief Medical Officer Mark Shearman - Chief Scientific Officer Bill Sulliva...

AGTC - Applied Genetic EPS misses by $0.04

Applied Genetic (NASDAQ: AGTC ): Q3 GAAP EPS of -$0.64 misses by $0.04 . More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

AGTC - AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2019

Company to host R&D Day on January 28, 2020, in New York GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based ...

AGTC - AGTC to Host First Quarter Results Conference Call and Webcast on November 12, 2019

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announce...

AGTC - AGTC Announces Stargardt Disease as its Second Preclinical Ophthalmology Program and Reports Compelling Preclinical Data Supporting the Potential of its Dual-Vector Technology

- Simultaneous delivery of two optimized AAV vectors expands the therapeutic and commercial potential of AGTC's industry-leading AAV platform by enabling delivery of DNA encoding larger proteins - GAINESVILLE, Fla., and CAMBRIDGE, Mass., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Applied Genetic...

AGTC - AGTC Presents Data Demonstrating Efficiency of its AAV Vectors for Ocular Gene Therapy Even in the Presence of Anti-AAV Antibodies

- Data support safety and potential clinical utility of AGTC’s ocular gene therapy candidates regardless of patients’ AAV antibody status- GAINESVILLE, Fla., and CAMBRIDGE, Mass., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), ...

AGTC - AGTC and Otonomy Announce Strategic Collaboration to Develop and Commercialize Gene Therapy for Congenital Hearing Loss

GAINESVILLE, Fla. and CAMBRIDGE, Mass. and SAN DIEGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, ...

AGTC - Thin ranks in premarket gainers

The9 (NASDAQ: NCTY ) +34%  on selling several subsidiaries to Kapler. More news on: The9 Limited, LATAM Airlines Group S.A., Applied Genetic Technologies Corporation, Stocks on the move, Read more ...

Previous 10 Next 10